PODCAST · science
NutraSift: The nutraceutical innovation podcast
by Siftlink SA
Following the latest trends in nutraceutical science
-
57
Lutein: The supplement industry's most successful clinical trial outcome is a carotenoid
The AREDS2 study (Age-Related Eye Disease Study 2) is one of the largest, most rigorous supplement trials ever conducted (4,203 participants, 5-year follow-up). It established that lutein/zeaxanthin was safer and equally effective as beta-carotene for AMD prevention. AREDS2 changed clinical practice worldwide. Lutein's commercial success is built on a single trial with a level of rigor most pharma drugs would envy.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23644932/https://pubmed.ncbi.nlm.nih.gov/24310343/https://pubmed.ncbi.nlm.nih.gov/35653117/
-
56
Astaxanthin: The reason salmon is pink is the reason your eyes are protected
Wild salmon, flamingos, and shrimp are pink/red because they accumulate astaxanthin from the food chain (microalgae -> krill -> fish). Astaxanthin crosses the blood-retinal barrier (unlike beta-carotene or lutein), depositing directly in the retina. The color of salmon is a visual marker of a compound that specifically protects the tissue that processes visual information.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281326/https://pubmed.ncbi.nlm.nih.gov/32370045/https://pubmed.ncbi.nlm.nih.gov/37897411/
-
55
Astaxanthin: 6,000x more potent than vitamin C
Most antioxidants (vitamin C, vitamin E, beta-carotene) can become pro-oxidant under certain conditions i.e donating an electron, then becoming a radical themselves. Astaxanthin is the only known carotenoid that quenches singlet oxygen and scavenges radicals without ever generating a pro-oxidant state. It literally cannot do harm through its antioxidant mechanism. This makes it structurally unique, not just "more potent."Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC7139534/https://pmc.ncbi.nlm.nih.gov/articles/PMC8746862/https://pmc.ncbi.nlm.nih.gov/articles/PMC6878783/
-
54
Cordyceps: The world's most expensive mushroom grows on caterpillars
Wild Ophiocordyceps sinensis (a fungus that parasitizes ghost moth caterpillars at 3,000-5,000m in the Tibetan Plateau) costs $20,000-50,000/kg. What consumers actually buy is cultivated Cordyceps militaris, a different species grown on grain substrate. The "cordyceps" on the label has almost nothing to do with the caterpillar fungus of traditional Chinese medicine. The name carries the heritage; the product is a modern cultivation innovation.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/29752731/https://www.ncbi.nlm.nih.gov/books/NBK92758/https://pmc.ncbi.nlm.nih.gov/articles/PMC3924981/
-
53
Reishi: The ganoderic acid alphabet
Reishi contains ganoderic acids A through Z (and beyond). Ganoderic acid A is anti-histaminic. Ganoderic acid D is hepatoprotective. Ganoderic acid F is anti-hypertensive. The market says "reishi extract" without specifying which ganoderic acids at what levels. The fractionation opportunity is the same as ginseng ginsenosides; enormous.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/31035236/https://pubmed.ncbi.nlm.nih.gov/40316150/https://pmc.ncbi.nlm.nih.gov/articles/PMC4417579/
-
52
Lion's Mane: A natural compound proven to stimulate nerve growth factor production
Hericenones (fruiting body) and erinacines (mycelium) are the only known natural compounds that cross the blood-brain barrier and directly stimulate NGF (nerve growth factor) synthesis. This makes Lion's Mane unique in the entire natural products space, no other mushroom, herb, or food has this mechanism. The neuroregeneration implications (Alzheimer's, nerve injury recovery, neuroplasticity) are profound. Yet the market is chaotic, most products don't distinguish between fruiting body (hericenones) and mycelium (erinacines), which contain different actives.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC5987239/https://pubmed.ncbi.nlm.nih.gov/24266378/https://pmc.ncbi.nlm.nih.gov/articles/PMC10650066/
-
51
Artichoke: The bitter compound that makes everything else taste sweet
Artichoke contains cynarin, which temporarily inhibits sweet taste receptors. After consuming cynarin, water tastes sweet. This peculiar sensory effect is actually a clue to cynarin's mechanism, it modulates taste receptors in the same family (TAS2Rs) that control gut bitter-taste signaling, bile secretion, and GLP-1 release. The "artichoke makes water taste sweet" parlor trick is a sensory window into a metabolic mechanism.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23195882/https://pubmed.ncbi.nlm.nih.gov/34048925/https://pubmed.ncbi.nlm.nih.gov/30120064/
-
50
Mango leaf: A mitochondrial bioenergetics enhancer from a tree that grows everywhere
Mangiferin (a xanthone in mango leaves) directly activates Complex II of the mitochondrial electron transport chain, a mechanism more commonly associated with pharmaceutical interventions than botanical ingredients. Nutriventia's Zynamite has clinical data showing improved reaction time and cognitive performance from this mechanism. The raw material is an agricultural waste product from the world's most widely grown tropical fruit.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/17585957/https://pubmed.ncbi.nlm.nih.gov/18602406/https://pmc.ncbi.nlm.nih.gov/articles/PMC4885513/
-
49
Tongkat Ali: A root that takes 15 years to mature
Eurycoma longifolia takes 7-15 years to reach harvestable maturity in the wild. This makes it one of the slowest-growing commercially relevant botanicals. Wild-harvesting is decimating Malaysian and Indonesian forests. The cultivation challenge is a supply bottleneck, but also a natural scarcity premium.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC10780575/https://pmc.ncbi.nlm.nih.gov/articles/PMC6274257/https://pubmed.ncbi.nlm.nih.gov/20434529/
-
48
Oleocanthal: the olive compound that works like ibuprofen
Extra virgin olive oil's throat-burning sensation comes from oleocanthal, which inhibits COX-1 and COX-2 at the same receptor site as ibuprofen. The "throat sting" is literally a pharmacological signal of anti-inflammatory activity. The stronger the burn, the more oleocanthal. This accidental bioassay has been used by olive oil producers for centuries without knowing the mechanism.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/16136122/https://pmc.ncbi.nlm.nih.gov/articles/PMC4139846/https://pmc.ncbi.nlm.nih.gov/articles/PMC10741130/
-
47
Tongkat Ali: The testosterone ingredient that actually works by lowering cortisol
Tongkat ali's mechanism isn't direct testosterone synthesis. Eurycomanone reduces SHBG (sex hormone-binding globulin), freeing bound testosterone, and lowers cortisol, shifting the testosterone-to-cortisol ratio. It's an anti-stress mechanism producing a testosterone outcome. This is important because it means tongkat ali doesn't carry the same safety concerns as actual testosterone boosters.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC3669033/https://pubmed.ncbi.nlm.nih.gov/23810842/https://pmc.ncbi.nlm.nih.gov/articles/PMC6274257/
-
46
Gotu kola: The ingredient the K-beauty industry uses but the supplement industry forgot
Centella asiatica is one of the most popular ingredients in Korean skincare (CICA creams). The cosmetic-grade market ($790M) is nearly double the supplement market. Yet the triterpenoids (asiaticoside, madecassoside) that stimulate collagen synthesis and wound healing work systemically too, cognitive enhancement via GABA-A modulation, neuroprotection. The supplement industry is leaving the most scientifically interesting applications to the beauty industry.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/31736679/https://pmc.ncbi.nlm.nih.gov/articles/PMC5587720/https://pubmed.ncbi.nlm.nih.gov/36756687/
-
45
Fenugreek: The GLP-1 ingredient nobody talks about
Fenugreek contains 4-hydroxyisoleucine (4-HI), an amino acid that stimulates glucose-dependent insulin secretion from pancreatic beta cells. This is GLP-1-adjacent biology at a mechanistic level. While berberine gets all the "natural GLP-1" attention, 4-HI from fenugreek has a more specific, insulin-secretagogue mechanism. Yet the fenugreek extract market is only $12 million.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/9519714/https://pmc.ncbi.nlm.nih.gov/articles/PMC6273931/https://pubmed.ncbi.nlm.nih.gov/10516120/
-
44
Mulberry leaf: The silkworm's food is a pharmaceutical-grade blood sugar drug
Mulberry leaf contains 1-deoxynojirimycin (1-DNJ), an iminosugar that inhibits alpha-glucosidase, the exact same mechanism as acarbose (Precose/Glucobay), a prescription diabetes drug. Clinical data shows 30%+ post-prandial glucose reduction. The mulberry tree was cultivated for centuries as silkworm feed; the medical application was hiding in the animal agriculture supply chain.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC4014974/https://pubmed.ncbi.nlm.nih.gov/17555327/https://pubmed.ncbi.nlm.nih.gov/18404344/
-
43
Bergamot: A citrus fruit that inhibits the same enzyme as statin drugs
Bergamot contains brutieridin and melitidin two flavonoids that competitively inhibit HMG-CoA reductase, the exact same enzyme target as atorvastatin (Lipitor), simvastatin (Zocor), and every other statin. No other citrus species has these compounds. And they come from one 100-km stretch of coastline in Calabria, Italy. Studies show 20-30% LDL reduction approaching statin-level effects.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/19572741/https://pubmed.ncbi.nlm.nih.gov/20843083/https://pmc.ncbi.nlm.nih.gov/articles/PMC6497409/
-
42
Pomegranate: A 3-year cardiovascular study that no other fruit has replicated
A landmark trial showed pomegranate juice reduced carotid artery intima-media thickness by 30% over 3 years. Long-term arterial regression studies are extraordinarily rare for any intervention drug or natural. No other fruit or botanical has replicated this duration and endpoint. It remains one of the most impressive cardiovascular findings for a food ingredient.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/15158307/https://pubmed.ncbi.nlm.nih.gov/19766760/https://pmc.ncbi.nlm.nih.gov/articles/PMC3514854/
-
41
Moringa: The 15% CAGR ingredient with the thinnest evidence in the top 50
Moringa is the fastest-growing botanical market (14.9% CAGR, $1.6B) but has only 20 clinical trials. Compare this with for example curcumin that has 200+ trials for a $93M market. Moringa sells almost entirely on nutritional profile claims, not mechanisms. The first company to map moringa's isothiocyanate (moringin) mechanism and patent the Nrf2 activation pathway owns the scientific story for a $6.6B projected market.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/30783799/https://pubmed.ncbi.nlm.nih.gov/25808883/https://pmc.ncbi.nlm.nih.gov/articles/PMC9916933/
-
40
Quercetin: Why it went viral during COVID
Quercetin opens zinc channels in cell membranes, allowing zinc to enter cells and inhibit viral RNA replication. The "quercetin + zinc" protocol wasn't arbitrary, there's a specific ionophore mechanism that explains the synergy. That same mechanism opens the door for quercetin as a bioavailability platform for other metal ions.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/25050823/https://pmc.ncbi.nlm.nih.gov/articles/PMC8950086/https://pubmed.ncbi.nlm.nih.gov/34514483/
-
39
Quercetin: The supplement that kills aging cells, literally!
Quercetin is a senolytic that selectively triggers apoptosis in senescent (zombie) cells by inhibiting BCL-2 family anti-apoptotic proteins. Dasatinib with quercetin is the gold-standard senolytic combination in clinical trials, shown to clear senescent cells and improve physical function in elderly subjects. This longevity mechanism makes quercetin the most underpriced ingredient in the supplement aisle. It sells as an "antioxidant" for $10/bottle but has a mechanism relevant to the $100B+ longevity market.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/31542391/https://pmc.ncbi.nlm.nih.gov/articles/PMC6796530/https://pmc.ncbi.nlm.nih.gov/articles/PMC8521777/
-
38
Pomegranate: The most interesting thing about pomegranate is what your gut bacteria make from it
Pomegranate ellagitannins (punicalagins) are barely absorbed. Your gut microbiota converts them to urolithins, particularly urolithin A, which induces mitophagy (clearance of damaged mitochondria). This is one of the most validated mechanisms in longevity science. But only ~40% of people produce urolithin A efficiently. The fruit isn't the product; the metabolite is and most people can't make it.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/27400265/https://pubmed.ncbi.nlm.nih.gov/32694802/https://pubmed.ncbi.nlm.nih.gov/35118817/
-
37
Spirulina isn't algae
Spirulina (Arthrospira platensis) is a cyanobacterium, not a true alga. It's prokaryotic (no nucleus), closer to bacteria than to the eukaryotic microalgae (chlorella, Haematococcus) it's constantly compared with. This taxonomic distinction matters: cyanobacteria can produce microcystins (hepatotoxins), and contamination from co-occurring Microcystis species is a real quality concern that the "superfood algae" branding overlooks.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC10302721/https://pmc.ncbi.nlm.nih.gov/articles/PMC10221061/https://pmc.ncbi.nlm.nih.gov/articles/PMC5371831/
-
36
Resveratrol: The anti-aging molecule whose anti-aging mechanism might be an artifact
Resveratrol's fame is built on SIRT1 activation (the "longevity gene"). But subsequent research showed the original SIRT1 activation data may have been a fluorescent assay artifact, the fluorophore, not resveratrol, was activating the enzyme. Resveratrol does activate SIRT1, but possibly indirectly via AMPK. The most famous mechanism in longevity nutrition might be partially wrong and it still works.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/19843076/https://pubmed.ncbi.nlm.nih.gov/15684413/https://pmc.ncbi.nlm.nih.gov/articles/PMC6324849/
-
35
Chlorella Growth Factor: the mysterious extract that nobody can fully characterize
CGF (Chlorella Growth Factor) is a proprietary term for a hot-water extract of chlorella containing nucleotide-peptide complexes that accelerate cell division. It was discovered in the 1950s when researchers noticed chlorella quadrupled every 20 hours, faster than any other green plant. The exact composition of CGF has never been fully characterized despite 70 years of commercial use.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC7522799/https://pmc.ncbi.nlm.nih.gov/articles/PMC4908087/https://pubmed.ncbi.nlm.nih.gov/31739107/
-
34
Sage- The kitchen herb that targets the same enzyme as Alzheimer's drugs
Sage inhibits acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), the same enzyme targets as donepezil (Aricept) and rivastigmine (Exelon), the standard-of-care Alzheimer's drugs. A single-dose RCT in healthy adults showed significant improvement in memory and attention after sage extract. The name "Salvia" comes from Latin "salvare" to save/heal. A kitchen spice has a drug-level mechanism for cognitive preservation.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/18350281/, https://pubmed.ncbi.nlm.nih.gov/12605619/, https://pmc.ncbi.nlm.nih.gov/articles/PMC6493168/
-
33
Spirulina- The blue pigment, not the green, is the active compound
Spirulina is sold as a "green superfood." But its primary bioactive compound is phycocyanin, a blue pigment (phycobiliprotein) that gives spirulina its blue-green color. Phycocyanin inhibits NADPH oxidase (a key inflammatory enzyme), is neuroprotective, and has 20x the antioxidant capacity of ascorbic acid on a molar basis. The "green" marketing obscures the fact that the active is blue.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/18158824/https://pubmed.ncbi.nlm.nih.gov/12769719/https://pmc.ncbi.nlm.nih.gov/articles/PMC9185767/
-
32
Lion's Mane- The fruiting body vs. mycelium debate is actually a mechanism question
Hericenones (fruiting body): smaller molecules, cross BBB, stimulate NGF in the brain. Erinacines (mycelium): larger diterpenoids, also stimulate NGF but with different potency and targets. The "fruiting body vs. mycelium" debate in the mushroom industry isn't about quality, it's about which active compound you want. That is a distinction that is not always clear to the consumers and to many companies. Publications of interest:https://pubmed.ncbi.nlm.nih.gov/26244378/https://pmc.ncbi.nlm.nih.gov/articles/PMC11172836/https://pmc.ncbi.nlm.nih.gov/articles/PMC6803874/
-
31
The real active in ginseng might not be a ginsenoside at all
Compound K (CK), the primary gut metabolite of PPD-type ginsenosides, is more potent than the parent compounds for anti-inflammatory, anti-cancer, and anti-diabetic activity. Only ~30% of people efficiently produce Compound K (microbiome-dependent). This means ginseng is a different drug in different people. Direct Compound K supplementation could bypass the microbiome variability entirely.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/32617041/https://pubmed.ncbi.nlm.nih.gov/31984805/https://pmc.ncbi.nlm.nih.gov/articles/PMC6026358/
-
30
Cranberry: The botanical whose mechanism is anti-adhesion, not anti-microbial
Cranberry A-type PACs don't kill bacteria. They prevent uropathogenic E. coli from attaching to bladder walls by inhibiting P-fimbriae adhesion. This is a fundamentally different mechanism from antibiotics , it doesn't create resistance, it prevents colonization. The mechanism is so specific that there's a validated dose-response: 36mg PAC-A/day is the threshold. Below that, nothing happens. Above it, significant UTI reduction. This is pharma-level mechanism specificity in a berry.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/16055161/https://pmc.ncbi.nlm.nih.gov/articles/PMC2873556/https://pubmed.ncbi.nlm.nih.gov/10872208/
-
29
Mulberry leaves contain more GABA than most GABA supplements
Morus alba leaves accumulate unusually high levels of gamma-aminobutyric acid (GABA). This means mulberry leaf extract could serve dual-purpose positioning: blood sugar management + relaxation/sleep,an unexpected combination from a single plant.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/16462030/, https://pmc.ncbi.nlm.nih.gov/articles/PMC9158535/, https://pubmed.ncbi.nlm.nih.gov/26743028/
-
28
Elderberry targets the same enzyme as Tamiflu and nobody puts that on the label
Elderberry cyanidin glycosides inhibit viral neuraminidase the same mechanism as oseltamivir (Tamiflu). That's a specific, defined, anti-viral target. But the industry markets elderberry as generic "immune support" because regulators won't allow anti-viral claims on a food supplement. The mechanism is there. The IP is there. The claim structure isn't.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23748498/https://pubmed.ncbi.nlm.nih.gov/19682714/https://pubmed.ncbi.nlm.nih.gov/29199545/
-
27
The only nutraceutical used as an IV hospital drug
Intravenous silibinin (Legalon SIL) is the standard of care for Amanita phalloides mushroom poisoning in European hospitals. Milk thistle is one of the only botanical ingredients that has crossed the line from supplement to emergency medicine. That level of clinical validation is almost unique in the natural products space.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/22352731/https://pubmed.ncbi.nlm.nih.gov/6862461/https://pubmed.ncbi.nlm.nih.gov/23330770/
-
26
Silybin A and Silybin B: same name, different molecule, different potency
Silymarin contains two isomers of silybin (A and B) with different 3D configurations and different biological activity. No commercial standardization distinguishes between them. A product optimized for the more potent isomer on metabolic targets would be a genuinely novel ingredient from a plant used for 2,000 years.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/22224281/https://pubmed.ncbi.nlm.nih.gov/34360650/https://pmc.ncbi.nlm.nih.gov/articles/PMC6150307/
-
25
The liver ingredient that might be more valuable for diabetes
Silymarin has been "the liver ingredient" for 2,000 years. But silybin (the most active flavonolignan in silymarin) activates IRS-1 phosphorylation and GLUT4 translocation core mechanisms of insulin sensitivity and glucose uptake. With 25% of the global population having NAFLD/MAFLD, the metabolic health repositioning of silymarin could be worth more than its entire current liver health market.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/25760026/https://pubmed.ncbi.nlm.nih.gov/24036369/https://pubmed.ncbi.nlm.nih.gov/32950646/
-
24
The most sustainable ingredient in nutraceuticals is a waste product
Grape seed extract comes from pomace ,the leftover skins, seeds, and stems from winemaking. Bordeaux alone produces enough pomace annually to supply the global OPC market many times over. It's one of the few botanical ingredients where the supply chain is up-cycled agricultural waste. And yet it's not marketed that way.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC11462180/https://pmc.ncbi.nlm.nih.gov/articles/PMC7447760/https://pmc.ncbi.nlm.nih.gov/articles/PMC6222734/
-
23
The French Paradox was never about wine; it was about a polymer chain length
Grape seed OPCs (oligomeric proanthocyanidins) come in dimers, trimers, and higher polymers. Dimers and trimers are absorbed intact and have direct vascular effects (NO pathway). Higher polymers are fermented by gut bacteria into phenylvalerolactones with their own bioactivity. The entire grape seed market standardizes on "% total polyphenols" ignoring that the chain length determines whether the compound acts in the bloodstream or the gut.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/11813991/https://pubmed.ncbi.nlm.nih.gov/11053514/https://pmc.ncbi.nlm.nih.gov/articles/PMC9854439/
-
22
EGCG doesn't work the way the label claims
Most green tea extract supplements say "antioxidant." The actual mechanism that drives weight management results is COMT inhibition (extending norepinephrine activity) + AMPK activation (thermogenesis). Those are pharmacological actions, not "antioxidant properties." Selling EGCG as an antioxidant is like selling aspirin as a headache remedy and ignoring its cardiovascular mechanism.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/30524290/https://pubmed.ncbi.nlm.nih.gov/18197555/https://pubmed.ncbi.nlm.nih.gov/28137482/
-
21
Green tea's real active might be an amino acid, not a catechin
L-theanine ,the amino acid that promotes alpha brain wave activity, is naturally co-present with EGCG in green tea. The calming focus of tea (vs. the jitteriness of coffee) is an L-theanine effect, not a catechin effect. Yet the entire green tea extract market is standardized on catechins/EGCG. The L-theanine is stripped out during most extraction processes. You extract the antioxidant but discard the nootropic.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/18296328/https://pubmed.ncbi.nlm.nih.gov/18841456/https://pubmed.ncbi.nlm.nih.gov/23883567/
-
20
The safest dose of green tea extract might be more dangerous than you think
EFSA set an 800mg/day upper limit for EGCG after reviewing hepatotoxicity cases. Some concentrated supplements deliver 400-500mg per capsule. Two capsules and you're above the safety limit. The same ingredient with 10,000+ studies proving benefit also has a documented signal for liver damage at doses that many products comfortably deliver. The therapeutic window is narrower than the market acknowledges.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/32625874/https://pmc.ncbi.nlm.nih.gov/articles/PMC7009618/https://pmc.ncbi.nlm.nih.gov/articles/PMC10060436/
-
19
Rhodiola is the only adaptogen with altitude performance data and the mechanism explains why
Salidroside modulates HIF-1alpha (hypoxia-inducible factor). This is the master switch for oxygen sensing in cells. No other adaptogen directly targets this pathway. That's why rhodiola has unique data on altitude performance, fatigue under hypoxic conditions, and VO2max enhancement that ashwagandha and ginseng don't match.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/34739769/https://pubmed.ncbi.nlm.nih.gov/22309741/https://pmc.ncbi.nlm.nih.gov/articles/PMC11610317/
-
18
Three species, three chemistry profiles, one label
E. purpurea (chicoric acid + alkamides), E. angustifolia (echinacoside + alkamides), E. pallida (echinacoside, few alkamides). These are pharmacologically different plants with different mechanisms sold interchangeably as "Echinacea." It's as if someone sold Arabica, Robusta, and Liberica as interchangeable "coffee" for clinical purposes.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/16102249/https://pmc.ncbi.nlm.nih.gov/articles/PMC4441164/https://pubmed.ncbi.nlm.nih.gov/11428661/
-
17
The $2 billion ingredient that clinical trials say 'doesn't work' because they test the wrong compounds
Cochrane reviews on echinacea for colds show mixed results. But most clinical trials used products standardized on polysaccharides or caffeic acid derivatives NOT alkamides. The alkamide-CB2 mechanism is the most pharmacologically compelling, the best-absorbed (lipophilic), and the least-studied in humans. We might be dismissing a $2B ingredient based on trials that tested the wrong fraction.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/24554461/https://pmc.ncbi.nlm.nih.gov/articles/PMC4068831/https://pubmed.ncbi.nlm.nih.gov/15921096/
-
16
Echinacea's most interesting compound targets the endocannabinoid system
Echinacea alkamides (isobutylamides) interact directly with CB2 endocannabinoid receptors. This makes echinacea technically an endocannabinoid system modulator, the same receptor system targeted by CBD. Yet the entire echinacea market is standardized on polysaccharides or chicoric acid, and the alkamide fraction is literally discarded in most extraction processes. The CB2 story could reposition echinacea from "cold remedy" to targeted immunomodulation.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/16142631/https://pubmed.ncbi.nlm.nih.gov/16547349/https://pmc.ncbi.nlm.nih.gov/articles/PMC8111300/
-
15
The $268 billion threat to every berberine company
The GLP-1 drug market (Ozempic, Wegovy, Mounjaro) will be $268B by 2030. Oral GLP-1 agonists are in Phase 3 trials. When a consumer can take a $5/day pill that is an actual GLP-1 agonist, what happens to the "natural GLP-1 support" supplement market? The nutraceutical window for berberine's metabolic positioning is 2-3 years. Companies that don't lock in mechanism-specific patents and clinical evidence now will be competing with pharma.Publications of interest:https://www.grandviewresearch.com/industry-analysis/glp-1-receptor-agonist-markethttps://pubmed.ncbi.nlm.nih.gov/37921026/https://pmc.ncbi.nlm.nih.gov/articles/PMC12668848/
-
14
Berberine was a dye before it was a supplement and that might explain its mechanism
Berberine's intense yellow color comes from its ability to intercalate into DNA. It literally slides between DNA base pairs. This same property explains its anti-microbial and anti-cancer mechanisms and also why it inhibits CYP3A4 (the same enzyme that metabolizes 50% of all drugs). The supplement industry rarely mentions that the same molecule that lowers blood sugar also creates significant drug interactions in ~30% of users.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/22316074/https://pubmed.ncbi.nlm.nih.gov/21870106/ https://pubmed.ncbi.nlm.nih.gov/34269665/
-
13
Berberine's GLP-1 mechanism isn't what influencers think it is
The "nature's Ozempic" claim is based on AMPK activation, an indirect, downstream effect. But berberine (specifically dihydroberberine) appears to directly stimulate GLP-1 secretion from intestinal L-cells through a separate, AMPK-independent pathway. The real GLP-1 story is actually more compelling than the marketing claim, but it requires a mechanistic understanding most companies don't have. That mechanism is patentable.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/38351702/https://pmc.ncbi.nlm.nih.gov/articles/PMC6155143/https://pubmed.ncbi.nlm.nih.gov/34481875/
-
12
The boswellia market standardizes on AKBA. The other 4 boswellic acids might be more interesting.
Alpha-boswellic acid, beta-boswellic acid, 11-keto-beta-boswellic acid, acetyl-beta-boswellic acid, each with different 5-LOX inhibition profiles and selectivity for downstream mediators. A boswellia extract optimized for microglial inflammation (brain) rather than systemic 5-LOX would be a different product, different IP, different market.Publications of Interest:https://pubmed.ncbi.nlm.nih.gov/1602379/, https://pubmed.ncbi.nlm.nih.gov/19374837/, https://pmc.ncbi.nlm.nih.gov/articles/PMC12669112/
-
11
Frankincense contains an antidepressant that crosses the blood-brain barrier
Incensole acetate, a compound found in boswellia resin (frankincense), activates TRPV3 ion channels in the brain and shows antidepressant and anxiolytic effects in animal models. It actually crosses the blood-brain barrier. Nobody in the supplement industry is talking about boswellia for mental health. Currently it is exclusively positioned for joints. The neuroinflammation angle is entirely virgin territory.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/18492727/, https://pmc.ncbi.nlm.nih.gov/articles/PMC2493463/, https://pubmed.ncbi.nlm.nih.gov/23015543/
-
10
The only botanical that targets 5-LOX instead of COX and nobody's marketing it that way
Curcumin, ginger, omega-3 they all target the COX pathway (same as ibuprofen). Boswellia (AKBA) is the only major botanical that selectively inhibits 5-lipoxygenase, a completely different inflammatory pathway producing leukotrienes, not prostaglandins. That's a unique mechanism shared with no other natural ingredient. Yet boswellia is marketed as "another joint ingredient" competing on the same shelf as curcumin. It should be positioned as the complementary mechanism.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23194864/https://pmc.ncbi.nlm.nih.gov/articles/PMC1909340/ https://pubmed.ncbi.nlm.nih.gov/7603462/
-
9
A $760M market built on an Ayurvedic mistranslation
"Ashwagandha" means "smell of horse" (ashwa = horse, gandha = smell) , referring to the root's odor. But it's been romantically reinterpreted as "strength of a stallion" in modern marketing. The actual mechanism, HPA-axis modulation, cortisol reduction, and GABA-ergic activity however has nothing to do with horses. The evidence is real: the brand story is an accidental mistranslation that worked.Publications of interest:https://pmc.ncbi.nlm.nih.gov/articles/PMC3252722/, https://pmc.ncbi.nlm.nih.gov/articles/PMC10147008/, https://pmc.ncbi.nlm.nih.gov/articles/PMC12252077/
-
8
The ashwagandha sleep mechanism nobody talks about
Most of ashwagandha's sleep marketing is based on cortisol-lowering data. But the actual sleep compound may be triethylene glycol, a simple organic molecule found in the leaf (not the root) that shows direct sleep-inducing activity in animal models via GABA-A modulation. KSM-66 uses only root. The sleep mechanism may be in the part of the plant the most popular extract throws away.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/28207892/, https://pmc.ncbi.nlm.nih.gov/articles/PMC5313221/, https://pmc.ncbi.nlm.nih.gov/articles/PMC10281725/
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Following the latest trends in nutraceutical science
HOSTED BY
Siftlink SA
CATEGORIES
Loading similar podcasts...